BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 9 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
13F holders, Q1 2021
Institutional positions in BioCardia, Inc. as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- No complete 13F data for Q4 2020
- Shares held
- 3.12M
- No complete 13F data for Q4 2020
- Total value
- $13.5M
- No complete 13F data for Q4 2020
Holders and value by quarter
Institutions reporting BCDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $1.65M |
| Q1 2026 | 18 | $831.1K |
| Q4 2025 | 20 | $812.3K |
| Q3 2025 | 18 | $551.9K |
| Q2 2025 | 16 | $593.2K |
| Q1 2025 | 12 | $623.8K |
| Q4 2024 | 13 | $272.2K |
| Q3 2024 | 9 | $316.6K |
| Q2 2024 | 10 | $227.8K |
| Q1 2024 | 22 | $790.8K |
| Q4 2023 | 24 | $1.37M |
| Q3 2023 | 16 | $709.6K |
| Q2 2023 | 23 | $4.43M |
| Q1 2023 | 23 | $4.09M |
| Q4 2022 | 25 | $4.87M |
| Q3 2022 | 23 | $3.17M |
| Q2 2022 | 26 | $3.10M |
| Q1 2022 | 24 | $5.49M |
| Q4 2021 | 23 | $5.78M |
| Q3 2021 | 22 | $9.01M |
| Q2 2021 | 20 | $12.3M |
| Q1 2021 | 19 | $13.5M |
Institutions, Q1 2021
Shares, value and share of portfolio for each institution holding BioCardia, Inc..
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 74 | $0 | 0.00% | – | – |
| Morgan Stanley | 983 | $4.00K | 0.00% | – | – |
| Tower Research Capital LLC (TRC) | 3,194 | $14.0K | 0.00% | – | – |
| Bank of America Corp | 5,735 | $25.0K | 0.00% | – | – |
| Bank of New York Mellon Corp | 15,197 | $66.0K | 0.00% | – | – |
| Northern Trust Corp | 19,226 | $83.0K | 0.00% | – | – |
| Citadel Advisors LLC | 21,547 | $94.0K | 0.00% | – | – |
| Engineers Gate Manager LP | 21,855 | $95.0K | 0.00% | – | – |
| Simplex Trading, LLC | 23,149 | $100.0K | 0.01% | – | – |
| Brown Advisory Inc | 33,085 | $144.0K | 0.00% | – | – |
| Marshall Wace, LLP | 39,962 | $173.0K | 0.00% | – | – |
| Advisor Group Holdings, Inc. | 44,301 | $192.0K | 0.00% | – | – |
| Squarepoint Ops LLC | 46,945 | $204.0K | 0.00% | – | – |
| Geode Capital Management, LLC | 62,168 | $269.0K | 0.00% | – | – |
| Vanguard Group Inc | 245,573 | $1.06M | 0.00% | – | – |
| Renaissance Technologies LLC | 305,200 | $1.32M | 0.00% | – | – |
| CM Management, LLC | 313,100 | $1.36M | 1.01% | – | – |
| Captrust Financial Advisors | 659,363 | $2.86M | 0.03% | – | – |
| Roumell Asset Management, LLC | 1,257,203 | $5.46M | 7.89% | – | – |